TrialBritish journal of haematology2020
Ruxolitinib for tocilizumab-refractory severe COVID-19 infection.
Andrew J Innes et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
25 papers cite it
this paperpooled itcites it
TrialBritish journal of haematology2020
Andrew J Innes et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.